CME Outcomes Evidence

Benefits

Risks & contraindications

Comparisons

Evidence quality

Highlighted claims

• CME produces superior surgical specimens compared with standard colectomy across pathological metrics. — Surgical and oncological outcomes of right hemicolectomy with complete mesocolic excision in the treatment of right colon cancer: study protocol for a single-centre retrospective cohort study
• RELARC found higher vascular injury in CME than in standard surgery even at experienced centres. — Surgical and oncological outcomes of right hemicolectomy with complete mesocolic excision in the treatment of right colon cancer: study protocol for a single-centre retrospective cohort study
• Open and laparoscopic approaches are both considered valid for CME, with laparoscopic CME offering faster recovery markers in meta-analysis. — Surgical and oncological outcomes of right hemicolectomy with complete mesocolic excision in the treatment of right colon cancer: study protocol for a single-centre retrospective cohort study
• Hohenberger's original CME series linked specimen improvements to lower local recurrence and higher cancer-related survival. — Surgical and oncological outcomes of right hemicolectomy with complete mesocolic excision in the treatment of right colon cancer: study protocol for a single-centre retrospective cohort study
• Retrospective series, registry analyses, and meta-analyses associate higher lymph node yield with improved survival, especially for right-sided lesions. — Surgical and oncological outcomes of right hemicolectomy with complete mesocolic excision in the treatment of right colon cancer: study protocol for a single-centre retrospective cohort study